Clinical trial
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary…
NCT00189124 · University of Michigan, Other · Completed
Key facts
| NCT number | NCT00189124 |
|---|---|
| Title | Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention |
| Official title | Does DHEA Improve Endothelial Dysfunction and Other Cardiovascular Risk Factors in Premenopausal Women With Systemic Lupus? |
| Lead sponsor | University of Michigan, Other |
| Collaborators | Arthritis Foundation |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus |
| Intervention type | Drug |
| Interventions | Dehydroepiandrosterone (DHEA) |
| Enrollment | 13 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | May 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: